Overview


According to FutureWise analysis the market for Obsessive Compulsive Disorder (OCD) Drug is expected to reach US$ 1.31 billion by 2031 at a CAGR of 9.90%.

Obsessive compulsive disorder (OCD), is an anxiety disorder that causes repetitive behavior and unreasonable thoughts. Obsessive compulsive disorder makes it difficult for a person not to be enslaved by a specific thought or fear. A person who is afraid of contamination might wash their hands repeatedly to ensure that they are clean. A person might also check the gas stove several times to make sure it is turned off. Obsessive-compulsive disorder is characterized by both obsessive and compulsive behaviors. However, it's possible for individuals to have one or the other. People with obsessive compulsive disorder often have thoughts such as fear of germs or dirt, worry about being contaminated, thoughts about religion or morality, superstitions and orderly things. They also think of ways to hurt themselves or others. People with obsessive compulsive disorder are prone to repeating certain words in an effort to reduce anxiety. They also tend to order or arrange things, accumulate wastes, and even empty wine bottles and food containers. Although the exact cause of OCD is unknown, there are possible causes. Psychotherapy and medication are both options. Cognitive behavior therapy (CBT), a type of psychotherapy, has proven useful in the treatment of OCD. Cognitive behavior therapy (CBT), teaches people multiple ways to think, react and handle a specific situation. Antidepressants are the most commonly prescribed medications to treat OCD. PANDAS is a condition in which a child with PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections) has to be treated with antibiotics. These medications include SSRI medicines (citalopram and escitalopram as well as fluoxetine and sertraline). There are many other opportunities for OCD drugs market growth due to the advancements in treatment, therapies, and novel treatments, as well as in anti-anxiety and antidepressant drugs. The market growth will be slowed by factors such as the expiry of patents on patented drugs, and the introduction of generic versions of branded drugs. This report on obsessive compulsive disorder (OCD), drugs market provides detailed information about market share, new developments and product pipeline analysis. It also analyzes opportunities in terms of emerging revenues pockets, changes to market regulations, product approvals and strategic decisions. For a brief analysis of the market, contact us to receive an analyst brief. Our team will assist you in creating a revenue-impact solution that achieves your goal. Due to the increasing prevalence of obsessive compulsive disorder, and increased government efforts to combat it. In the future, the region will also dominate the obsessive compulsive disorder drugs market. The industry is also seeing a rise in acceptance of non-approved drugs when combined with approved therapies.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Obsessive Compulsive Disorder (OCD) Drug Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Obsessive Compulsive Disorder (OCD) Drug Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott
  • Pfizer Inc
  • MerckCo. inc
  • Sanofi
  • Novartis AG
  • Abbvie Inc
  • Eli Lilly and Company
  • Astrazeneca
  • Meiji Holdings Co. Ltd.
  • Brainsway
  • Sellas
  • Mylan N.V.
  • Addex therapeutics
  • F.hoffmann-La Roche Ltd
  • Omeros Corporation
  • C4X discovery holdings plc
  • Zydus Cadila

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Therapy Type

  • Conatmination Obessions
  • Checking Compulsions
  • Obessions Without Visible Compulsions
  • Symmetery Obessions with Ordering Compulsions
  • Hoarding

By Symptoms Type

  • Coagnitive Behavioural Therapy
  • Augmentation Therapy
  • Aversion Therapy
  • Systematic Desensitization
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Drug Store
  • Retail Pharmacy

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Obsessive Compulsive Disorder (OCD) Drug Market By Therapy Type, By Symptoms Type, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Obsessive Compulsive Disorder (OCD) Drug Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Obsessive Compulsive Disorder (OCD) Drug Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Obsessive Compulsive Disorder (OCD) Drug Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Obsessive Compulsive Disorder (OCD) Drug Market, By Therapy Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Conatmination Obessions
        2. Checking Compulsions
        3. Obessions Without Visible Compulsions
        4. Symmetery Obessions with Ordering Compulsions
        5. Hoarding

  • 8.   Obsessive Compulsive Disorder (OCD) Drug Market, By Symptoms Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Coagnitive Behavioural Therapy
        2. Augmentation Therapy
        3. Aversion Therapy
        4. Systematic Desensitization
        5. Others

  • 9.   Obsessive Compulsive Disorder (OCD) Drug Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacy
        2. Online Pharmacy
        3. Drug Store
        4. Retail Pharmacy

  • 10.   North America Obsessive Compulsive Disorder (OCD) Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Obsessive Compulsive Disorder (OCD) Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Obsessive Compulsive Disorder (OCD) Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Obsessive Compulsive Disorder (OCD) Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Pfizer Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. MerckCo. inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Sanofi
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Novartis AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Abbvie Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Eli Lilly and Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Astrazeneca
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Meiji Holdings Co. Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Brainsway
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Sellas
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Mylan N.V.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Addex therapeutics
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
          14. F.hoffmann-La Roche Ltd
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Omeros Corporation
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. C4X discovery holdings plc
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Zydus Cadila
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients